233 related articles for article (PubMed ID: 22837104)
1. Use of a computerized medication shared decision making tool in community mental health settings: impact on psychotropic medication adherence.
Stein BD; Kogan JN; Mihalyo MJ; Schuster J; Deegan PE; Sorbero MJ; Drake RE
Community Ment Health J; 2013 Apr; 49(2):185-92. PubMed ID: 22837104
[TBL] [Abstract][Full Text] [Related]
2. Use of a Web-Based Shared Decision-Making Program: Impact on Ongoing Treatment Engagement and Antipsychotic Adherence.
Finnerty MT; Layman DM; Chen Q; Leckman-Westin E; Bermeo N; Ng-Mak DS; Rajagopalan K; Hoagwood KE
Psychiatr Serv; 2018 Dec; 69(12):1215-1221. PubMed ID: 30286709
[TBL] [Abstract][Full Text] [Related]
3. A structured medication review tool to promote psychotropic medication optimisation for adults with intellectual disability: feasibility study.
Sheehan R; Strydom A; Marston L; Morant N; Fiori F; Santosh P; Hassiotis A
BMJ Open; 2019 Dec; 9(12):e033827. PubMed ID: 31843854
[TBL] [Abstract][Full Text] [Related]
4. Decision making in recovery-oriented mental health care.
Matthias MS; Salyers MP; Rollins AL; Frankel RM
Psychiatr Rehabil J; 2012; 35(4):305-14. PubMed ID: 22491370
[TBL] [Abstract][Full Text] [Related]
5. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs.
Svarstad BL; Shireman TI; Sweeney JK
Psychiatr Serv; 2001 Jun; 52(6):805-11. PubMed ID: 11376229
[TBL] [Abstract][Full Text] [Related]
6. Adherence to Psychotropic Medications and Associated Factors in Primary Health Care.
Miasso AI; Telles Filho PC; Borges TL; Pereira Júnior AD; Giacchero Vedana KG; Shasanmi R; Escobar Gimenes FR
Issues Ment Health Nurs; 2016 Oct; 37(10):775-783. PubMed ID: 27548290
[TBL] [Abstract][Full Text] [Related]
7. Use of outpatient mental health services and psychotropic medications among HIV-infected patients in a multisite, multistate study.
Himelhoch S; Josephs JS; Chander G; Korthuis PT; Gebo KA;
Gen Hosp Psychiatry; 2009; 31(6):538-45. PubMed ID: 19892212
[TBL] [Abstract][Full Text] [Related]
8. Predictors of medication adherence in children receiving psychotropic medication.
Dean AJ; Wragg J; Draper J; McDermott BM
J Paediatr Child Health; 2011 Jun; 47(6):350-5. PubMed ID: 21309880
[TBL] [Abstract][Full Text] [Related]
9. Shared decision making and serious mental illness.
Mahone IH
Arch Psychiatr Nurs; 2008 Dec; 22(6):334-43. PubMed ID: 19026922
[TBL] [Abstract][Full Text] [Related]
10. Integrating Client and Clinician Perspectives on Psychotropic Medication Decisions: Developing a Communication-Centered Epistemic Model of Shared Decision Making for Mental Health Contexts.
Mikesell L; Bromley E; Young AS; Vona P; Zima B
Health Commun; 2016; 31(6):707-17. PubMed ID: 26529605
[TBL] [Abstract][Full Text] [Related]
11. Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.
Zito JM; Safer DJ; Zuckerman IH; Gardner JF; Soeken K
Psychiatr Serv; 2005 Feb; 56(2):157-63. PubMed ID: 15703342
[TBL] [Abstract][Full Text] [Related]
12. Experiences of psychotropic medication use and decision-making for adults with intellectual disability: a multistakeholder qualitative study in the UK.
Sheehan R; Hassiotis A; Strydom A; Morant N
BMJ Open; 2019 Nov; 9(11):e032861. PubMed ID: 31780594
[TBL] [Abstract][Full Text] [Related]
13. Psychotropic medication non-adherence among patients with severe mental disorder attending at Bahir Dar Felege Hiwote Referral hospital, north west Ethiopia, 2017.
Gebeyehu DA; Mulat H; Bekana L; Asemamaw NT; Birarra MK; Takele WW; Angaw DA
BMC Res Notes; 2019 Feb; 12(1):102. PubMed ID: 30808408
[TBL] [Abstract][Full Text] [Related]
14. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
Houghton R; Ong RC; Bolognani F
Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
[TBL] [Abstract][Full Text] [Related]
15. Increase Adherence to Psychotropic Medication Through Motivational Adherence Therapy: A Quality Improvement Project.
Hughes F; Vess J; Johnson E
Issues Ment Health Nurs; 2018 Aug; 39(8):709-713. PubMed ID: 29847199
[TBL] [Abstract][Full Text] [Related]
16. Use of HIV and psychotropic medications among persons with serious mental illness and HIV/AIDS.
Lee S; Rothbard AB; Noll E; Blank MB
Adm Policy Ment Health; 2011 Sep; 38(5):335-44. PubMed ID: 20976619
[TBL] [Abstract][Full Text] [Related]
17. "When I Stop My Medication, Everything Goes Wrong": Content Analysis of Interviews with Adolescent Patients Treated with Psychotropic Medication.
Niemeyer L; Schumm L; Mechler K; Jennen-Steinmetz C; Dittmann RW; Häge A
J Child Adolesc Psychopharmacol; 2018 Nov; 28(9):655-662. PubMed ID: 30148662
[TBL] [Abstract][Full Text] [Related]
18. Effects of antipsychotic medication on psychiatric service utilization and cost.
Rothbard A; Murrin MR; Jordan N; Kuno E; McFarland BH; Stroup TS; Morrissey JP; Stiles PG; Boothroyd RA; Merwin E; Shern DL
J Ment Health Policy Econ; 2005 Jun; 8(2):83-93. PubMed ID: 15998980
[TBL] [Abstract][Full Text] [Related]
19. Facilitators and barriers to the active participation of clients with serious mental illnesses in medication decision making: the perceptions of young adult clients.
Delman J; Clark JA; Eisen SV; Parker VA
J Behav Health Serv Res; 2015 Apr; 42(2):238-53. PubMed ID: 25056768
[TBL] [Abstract][Full Text] [Related]
20. Psychotropic medication adherence in correctional facilities: a review of the literature.
Shelton D; Ehret MJ; Wakai S; Kapetanovic T; Moran M
J Psychiatr Ment Health Nurs; 2010 Sep; 17(7):603-13. PubMed ID: 20712683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
